UTHR Exercise Disclosure
Rothblatt Martine A · SEC Form 4 · Filed Jul 24, 2026
Exercise
Calculated transaction value
$0
Rothblatt Martine A Chairperson & CEO
UTHR
Transaction date
Jul 23, 2026
Public filing date
Jul 24, 2026
Filing lag
Filed 1 day later
UTHR daily price context
Close on/before transaction
$529.53
Jul 23, 2026
Close before public filing
$529.53
Jul 23, 2026
Return since public filing
-7.92%
Through Sep 7, 2026
Source details
- Reported owner
- Not disclosed
- Source asset code
- Derivative
- Security
- Stock Option on Common Stock
- Quantity / price
- 9,500 shares @ $0
- SEC ownership
- Indirect
- Transaction code
- M
- Form
- 4
- Filing identifier
- 0001106578-26-000105
Filing cohort
Transactions in this filing
Showing 12 of 12
Trades
12
Issuers
1
Estimated value
$6.31M
Buys / sales
0 / 10
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| United Therapeutics Corp UTHR | Exercise | Jul 23, 2026 | $1.29M |
| United Therapeutics Corp UTHR | Sale | Jul 23, 2026 | $130.19K |
| United Therapeutics Corp UTHR | Sale | Jul 23, 2026 | $1.05M |
| United Therapeutics Corp UTHR | Sale | Jul 23, 2026 | $1.21M |
| United Therapeutics Corp UTHR | Sale | Jul 23, 2026 | $106.37K |
| United Therapeutics Corp UTHR | Sale | Jul 23, 2026 | $177.54K |
| United Therapeutics Corp UTHR | Sale | Jul 23, 2026 | $89.75K |
| United Therapeutics Corp UTHR | Sale | Jul 23, 2026 | $203.5K |
| United Therapeutics Corp UTHR | Sale | Jul 23, 2026 | $290.84K |
| United Therapeutics Corp UTHR | Sale | Jul 23, 2026 | $1.13M |
| United Therapeutics Corp UTHR | Sale | Jul 23, 2026 | $637.54K |
| United Therapeutics Corp UTHR Current | Exercise | Jul 23, 2026 | $0 |